Valneva SE (VALN) | Stock Overview & Key Data
Valneva SE Performance Comparison
Stock Range
Today's Range
Low: $11.18
High: $11.62
on August 21, 2025
52 Week Range
Low: $3.62
High: $12.25
on December 17, 2024
on August 19, 2025
All-Time High: $67.84 on November 29, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.0B
EPS
-1.08
P/E Ratio (TTM)
72.74
Forward P/E
-21.68
P/B Ratio
10.84
PEG Ratio
-21.68
Div. Yield
N/A
ROE
-38.02%
Beta
0.998
Debt to Equity
105.63
Financial Highlights
Profitability
Gross Margin
50.10%
Operating Margin
-22.01%
Profit Margin
-34.15%
Returns and Earnings
Return on Assets (TTM)
-6.58%
Return on Equity (TTM)
-38.02%
EBITDA
$40.9M
Net Income (TTM)
$-78.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.21
Quarterly Revenue Growth (YoY)
27.00%
Quarterly Earnings Growth (YoY)
48.25%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Valneva SE VALN | 1.03B Small-cap | 6.88% | 76.22% | 77.62% | 50.40% | 137.08% | 44.20% | -37.94% | -62.07% |
| Vertex VRTX | 100.19B Large-cap | 1.83% | -13.31% | -8.70% | -17.92% | -2.05% | -17.41% | 41.10% | 47.23% |
| Regeneron REGN | 62.88B Large-cap | 5.69% | 9.65% | -1.07% | -14.59% | -16.36% | -50.12% | 0.33% | -0.74% |
| Cg Oncology CGON | 1.99B Small-cap | 0.08% | -3.42% | -0.92% | -6.71% | -10.32% | -29.82% | -25.83% | -25.83% |
| Adaptive ADPT | 1.99B Small-cap | -2.24% | 22.50% | 38.94% | 52.72% | 104.04% | 159.88% | 20.52% | -69.05% |
| Vericel VCEL | 1.80B Small-cap | -0.92% | -0.06% | -13.71% | -31.85% | -35.69% | -28.10% | 30.92% | 116.49% |
Ownership & Short Interest
Insider Ownership
0.00%
Institutional Ownership
5.56%
Shares Short
46K
Short Ratio
1.10
Short % of Shares Outstanding
0.06%
Average 10-Day Volume
126K
Average 90-Day Volume
74K
Valneva SE Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Valneva SE would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VALN's 52-week high and low?
- In the last 52 weeks, Valneva SE reached a high of $12.25 (on August 19, 2025) and a low of $3.62 (on December 17, 2024).
- What is the market cap and P/E ratio for VALN?
- Curious about Valneva SE's size and valuation? Its market capitalization stands at 1.03B. When it comes to valuation, the P/E ratio (trailing twelve months) is 72.74, and the forward P/E (looking ahead) is -21.68.
- Does VALN pay dividends? If so, what's the yield?
- As for dividends, Valneva SE isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Valneva SE's main competitors or similar companies to consider before investing?
When looking at Valneva SE, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX100.19B Healthcare Biotechnology -17.41% 41.10% Regeneron
REGN62.88B Healthcare Biotechnology -50.12% 0.33% Cg Oncology
CGON1.99B Healthcare Biotechnology -29.82% -25.83% Adaptive
ADPT1.99B Healthcare Biotechnology 159.88% 20.52% Vericel
VCEL1.80B Healthcare Biotechnology -28.10% 30.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Valneva SE? (e.g., ROE, Debt/Equity)
- To get a sense of Valneva SE's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -38.02%, the Debt to Equity ratio from the most recent quarter is 105.63, and its Gross Profit Margin stands at 50.10%.
- What is the recent revenue and earnings growth for VALN?
- Looking at Valneva SE's growth, its revenue over the trailing twelve months (TTM) was $229M. Compared to the same quarter last year (YoY), quarterly revenue grew by 27.00%, and quarterly earnings saw a YoY growth of 48.25%.
- How much of VALN stock is held by insiders and institutions?
- Wondering who owns Valneva SE stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.56%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.